[3-31]-Sermaglutide is an N-terminally truncated sermaglutide fragment spanning residues 3 to 31 of the parent sequence. Removal of flanking residues modifies helix length, amphipathicity, and receptor-contact patterns. Researchers use it to dissect domain contributions to binding and signaling in vitro. Applications include GLP-1 motif analysis, analog design, and structure-activity profiling.
[3-31]-Sermaglutide is a synthetic peptide analog derived from the glucagon-like peptide-1 (GLP-1) family, engineered to contain amino acid residues 3 through 31 of the native sermaglutide sequence. As a truncated GLP-1 receptor agonist, it embodies a critical segment for receptor interaction, making it a valuable tool for probing peptide-receptor dynamics, structure-activity relationships, and the molecular underpinnings of peptide-based signaling. Its design facilitates targeted studies on peptide stability, receptor selectivity, and downstream signaling mechanisms, supporting a broad range of research initiatives in peptide pharmacology and metabolic regulation.
Peptide-receptor interaction studies: Researchers utilize [3-31]-Sermaglutide to systematically investigate the binding affinity and activation profile of truncated GLP-1 analogs at the GLP-1 receptor. By isolating the core active region, the peptide provides a focused model for dissecting the minimal structural requirements for receptor engagement, enabling detailed mapping of ligand-receptor contact points. Such studies are essential for understanding how modifications to the peptide backbone influence receptor specificity and functional outcomes.
Structure-activity relationship (SAR) analysis: The compound is widely employed in SAR investigations to determine how specific amino acid sequences and truncations affect biological activity. By comparing the functional properties of [3-31]-Sermaglutide with those of full-length and other truncated GLP-1 analogs, scientists can delineate the contributions of individual residues to peptide stability, receptor activation, and resistance to proteolytic degradation. This knowledge supports rational peptide design and optimization for research applications.
Peptide synthesis and modification research: [3-31]-Sermaglutide serves as a model substrate in peptide synthesis laboratories, providing a testbed for evaluating novel solid-phase synthesis techniques, purification protocols, and peptide modification strategies. Its defined sequence allows researchers to assess the impact of chemical modifications, such as acylation or PEGylation, on peptide solubility, structural integrity, and functional performance. These studies contribute to the advancement of peptide engineering and the development of optimized analogs for experimental use.
Cellular signaling investigations: In vitro assays employing [3-31]-Sermaglutide enable precise examination of GLP-1 receptor-mediated signaling cascades. By applying the peptide to cultured cell systems expressing the GLP-1 receptor, researchers can monitor downstream events such as cAMP production, kinase activation, and gene expression changes. These experiments help elucidate the mechanistic pathways activated by specific peptide fragments and inform the design of selective GLP-1 receptor modulators.
Metabolic pathway exploration: The truncated peptide is also utilized as a tool to probe metabolic pathways regulated by GLP-1 receptor agonism. In biochemical research settings, it allows for the dissection of peptide-driven effects on glucose metabolism, insulin secretion, and energy homeostasis without the confounding influence of extraneous sequence regions. Such targeted studies are instrumental in clarifying the molecular basis of GLP-1-mediated metabolic regulation and in identifying novel intervention points for experimental modulation of metabolic processes.
1. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
4. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More